NETHERLANDS: Central Research Committee announces approval fastrack for trials to develop COVID 19 vaccines

2024-02-29T13:55:20+00:00March 19th, 2020|Categories: Europe, Western Europe|Tags: , , , , , |

The Netherlands’ Central Committee on Research Involving Human Subjects (CCMO) announced the availability of fast-track approval procedures for clinical trials related to the development of vaccines for COVID-19. To make use of this procedure, please contact CCMO via ccmo@ccmo.nl or telephone [...]

GREECE: EOM changes opening hours during COVID-19 emergency

2024-02-26T11:19:29+00:00March 19th, 2020|Categories: Europe, Western Europe|Tags: , , , , |

The Department of the General Secretariat of the National Organization for Medicines (EOM) announced the adoption of preventive measures and under the protection of public health against the coronavirus will operate from 10:00 to 14:00 during working days for the [...]

NORWAY: NoMA allows changes and safety measures in clinical research prior to approval during COVID-19 emergency

2024-02-29T13:58:34+00:00March 19th, 2020|Categories: Europe, Western Europe|Tags: , , , , |

Norwegian Medicine Agency (NoMA) guided many aspects of clinical research in response to COVID-19 emergency. Meditrial manages several studies in Norway and has direct connections with Investigators, hospitals and local Ethics Committees. Please feel free to contact us for advice [...]

ITALY activates safeguard procedures for clinical trials during pandemic

2024-02-26T12:32:21+00:00March 19th, 2020|Categories: Europe, Western Europe|Tags: , , , , , |

The Italian Medicines Agency provides indications regarding the management of clinical trials in Italy during the COVID-19 (coronavirus disease 19) emergency. The guidelines describe the measures to manage clinical trials during the emergency and the exemptions granted. Download in [...]

GERMANY: BfArM provides support for ongoing clinical trials

2024-02-26T11:10:55+00:00March 18th, 2020|Categories: Europe, Western Europe|Tags: , , , , , |

Germany reacts to the pandemic with high attention to ongoing clinical trials. According to the government authority BfArM, protocol deviations and changes may occur with the dynamic risk situation and restrictions due to Coronavirus SARS-CoV-2. A dedicated email, CT-COVID@bfarm.de, [...]

PORTUGAL: Ethics Committee (CEIC) guidance on how to act towards COVID-19 in clinical trials

2024-02-29T14:03:18+00:00March 17th, 2020|Categories: Europe, Western Europe|Tags: , , , , |

Although the Ministry of Health (INFARMED) did not provide any guidelines so far, we understand that CEIC guidelines have been developed with the INFARMED team. Meditrial has direct connections with Investigators, hospitals and Portuguese Ethics Committees. Please feel free to [...]

AUSTRIA: BASG on safety measures for clinical research during COVID-19 emergency

2024-02-01T15:07:37+00:00March 17th, 2020|Categories: Europe, Western Europe|Tags: , , , , |

Austrian Health Authority (BASG) issued recommendations on measures for patient safety and communication with the authority during COVID-19 emergency. Meditrial manages several studies in Austria and has direct connections with Investigators, hospitals and local Ethics Committees. Please feel free to [...]

Go to Top